The epigenetic factor BORIS (CTCFL) controls the androgen receptor regulatory network in ovarian cancer
Sign Up to like & getrecommendations! Published in 2019 at "Oncogenesis"
DOI: 10.1038/s41389-019-0150-2
Abstract: The identification of prognostic biomarkers is a priority for patients suffering from high-grade serous ovarian cancer (SOC), which accounts for >70% of ovarian cancer (OC) deaths. Meanwhile, borderline ovarian cancer (BOC) is a low malignancy… read more here.
Keywords: network; boris ctcfl; boris; expression ... See more keywords